Fazli L - Search Results

1

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.

Vandekerkhove G, Lavoie JM, Annala M, Murtha AJ, Sundahl N, Walz S, Sano T, Taavitsainen S, Ritch E, Fazli L, Hurtado-Coll A, Wang G, Nykter M, Black PC, Todenhöfer T, Ost P, Gibb EA, Chi KN, Eigl BJ, Wyatt AW. Vandekerkhove G, et al. Among authors: fazli l. Nat Commun. 2021 Jan 8;12(1):184. doi: 10.1038/s41467-020-20493-6. Nat Commun. 2021. PMID: 33420073 Free PMC article.

2

Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.

Rocchi P, So A, Kojima S, Signaevsky M, Beraldi E, Fazli L, Hurtado-Coll A, Yamanaka K, Gleave M. Rocchi P, et al. Among authors: fazli l. Cancer Res. 2004 Sep 15;64(18):6595-602. doi: 10.1158/0008-5472.CAN-03-3998. Cancer Res. 2004. PMID: 15374973

3

Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.

Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME. Krueckl SL, et al. Among authors: fazli l. Cancer Res. 2004 Dec 1;64(23):8620-9. doi: 10.1158/0008-5472.CAN-04-2446. Cancer Res. 2004. PMID: 15574769

4

A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer.

Chi KN, Eisenhauer E, Fazli L, Jones EC, Goldenberg SL, Powers J, Tu D, Gleave ME. Chi KN, et al. Among authors: fazli l. J Natl Cancer Inst. 2005 Sep 7;97(17):1287-96. doi: 10.1093/jnci/dji252. J Natl Cancer Inst. 2005. PMID: 16145049 Clinical Trial.

5

Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors.

Wafa LA, Palmer J, Fazli L, Hurtado-Coll A, Bell RH, Nelson CC, Gleave ME, Cox ME, Rennie PS. Wafa LA, et al. Among authors: fazli l. Hum Pathol. 2007 Jan;38(1):161-70. doi: 10.1016/j.humpath.2006.07.003. Epub 2006 Sep 25. Hum Pathol. 2007. PMID: 16997353

6

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.

Rajput AB, Miller MA, De Luca A, Boyd N, Leung S, Hurtado-Coll A, Fazli L, Jones EC, Palmer JB, Gleave ME, Cox ME, Huntsman DG. Rajput AB, et al. Among authors: fazli l. J Clin Pathol. 2007 Nov;60(11):1238-43. doi: 10.1136/jcp.2006.043810. Epub 2007 Jan 26. J Clin Pathol. 2007. PMID: 17259299 Free PMC article.

7

A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.

Hadaschik BA, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, Gleave ME, So AI. Hadaschik BA, et al. Among authors: fazli l. BJU Int. 2007 Dec;100(6):1377-84. doi: 10.1111/j.1464-410X.2007.07165.x. Epub 2007 Sep 10. BJU Int. 2007. PMID: 17850390

8

Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.

Sowery RD, Hadaschik BA, So AI, Zoubeidi A, Fazli L, Hurtado-Coll A, Gleave ME. Sowery RD, et al. Among authors: fazli l. BJU Int. 2008 Aug;102(3):389-97. doi: 10.1111/j.1464-410X.2008.07618.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336596 Clinical Trial.

9

Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer.

So AI, Levitt RJ, Eigl B, Fazli L, Muramaki M, Leung S, Cheang MC, Nielsen TO, Gleave M, Pollak M. So AI, et al. Among authors: fazli l. Clin Cancer Res. 2008 Nov 1;14(21):6944-54. doi: 10.1158/1078-0432.CCR-08-0408. Clin Cancer Res. 2008. PMID: 18980989

10

Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.

Musende AG, Eberding A, Wood C, Adomat H, Fazli L, Hurtado-Coll A, Jia W, Bally MB, Guns ET. Musende AG, et al. Among authors: fazli l. Cancer Chemother Pharmacol. 2009 Nov;64(6):1085-95. doi: 10.1007/s00280-009-0965-1. Epub 2009 Mar 20. Cancer Chemother Pharmacol. 2009. PMID: 19301006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters